vs
ADMA BIOLOGICS, INC.（ADMA）与AIM ImmunoTech Inc.（AIM）财务数据对比。点击上方公司名可切换其他公司
ADMA BIOLOGICS, INC.的季度营收约是AIM ImmunoTech Inc.的6626.8倍（$139.2M vs $21.0K）。ADMA BIOLOGICS, INC.净利率更高（35.5% vs -19881.0%，领先19916.4%）。ADMA BIOLOGICS, INC.同比增速更快（18.4% vs -53.3%）。过去两年ADMA BIOLOGICS, INC.的营收复合增速更高（30.4% vs -27.5%）
ADMA生物制剂公司是一家专注于研发、生产及商业化特种血浆来源免疫球蛋白疗法的生物制药企业，主要面向美国市场，为原发性免疫缺陷及其他免疫相关疾病患者、医护人员和医疗机构提供免疫健康领域的治疗方案。
AIM ImmunoTech是一家总部位于美国佛罗里达州奥卡拉的生物制药企业，前身是Hemispherx Biopharma，1990年成立，目前专注于研发用于治疗多种癌症、各类病毒感染以及免疫缺陷疾病的创新疗法。
ADMA vs AIM — 直观对比
营收规模更大
ADMA
是对方的6626.8倍
$21.0K
营收增速更快
ADMA
高出71.7%
-53.3%
净利率更高
ADMA
高出19916.4%
-19881.0%
两年增速更快
ADMA
近两年复合增速
-27.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $139.2M | $21.0K |
| 净利润 | $49.4M | $-4.2M |
| 毛利率 | 63.8% | — |
| 营业利润率 | 45.1% | -14057.1% |
| 净利率 | 35.5% | -19881.0% |
| 营收同比 | 18.4% | -53.3% |
| 净利润同比 | -55.9% | 30.0% |
| 每股收益（稀释后） | $0.20 | $-6.46 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADMAAIM
| Q4 25 | $139.2M | $21.0K | ||
| Q3 25 | $134.2M | $26.0K | ||
| Q2 25 | $122.0M | $25.0K | ||
| Q1 25 | $114.8M | $16.0K | ||
| Q4 24 | $117.5M | $45.0K | ||
| Q3 24 | $119.8M | $35.0K | ||
| Q2 24 | $107.2M | $50.0K | ||
| Q1 24 | $81.9M | $40.0K |
净利润ADMAAIM
| Q4 25 | $49.4M | $-4.2M | ||
| Q3 25 | $36.4M | $-3.3M | ||
| Q2 25 | $34.2M | $-2.8M | ||
| Q1 25 | $26.9M | $-3.7M | ||
| Q4 24 | $111.9M | $-6.0M | ||
| Q3 24 | $35.9M | $-3.7M | ||
| Q2 24 | $32.1M | $-1.8M | ||
| Q1 24 | $17.8M | $-5.8M |
毛利率ADMAAIM
| Q4 25 | 63.8% | — | ||
| Q3 25 | 56.3% | — | ||
| Q2 25 | 55.1% | — | ||
| Q1 25 | 53.2% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 49.8% | — | ||
| Q2 24 | 53.6% | — | ||
| Q1 24 | 47.8% | — |
营业利润率ADMAAIM
| Q4 25 | 45.1% | -14057.1% | ||
| Q3 25 | 38.0% | -9411.5% | ||
| Q2 25 | 35.1% | -10584.0% | ||
| Q1 25 | 30.4% | -22618.8% | ||
| Q4 24 | 32.6% | -13011.1% | ||
| Q3 24 | 33.1% | -12825.7% | ||
| Q2 24 | 36.6% | -7388.0% | ||
| Q1 24 | 26.7% | -14335.0% |
净利率ADMAAIM
| Q4 25 | 35.5% | -19881.0% | ||
| Q3 25 | 27.1% | -12630.8% | ||
| Q2 25 | 28.1% | -11176.0% | ||
| Q1 25 | 23.4% | -23156.3% | ||
| Q4 24 | 95.2% | -13260.0% | ||
| Q3 24 | 30.0% | -10571.4% | ||
| Q2 24 | 29.9% | -3672.0% | ||
| Q1 24 | 21.7% | -14542.5% |
每股收益（稀释后）ADMAAIM
| Q4 25 | $0.20 | $-6.46 | ||
| Q3 25 | $0.15 | $1.57 | ||
| Q2 25 | $0.14 | $-3.68 | ||
| Q1 25 | $0.11 | $-0.05 | ||
| Q4 24 | $0.45 | $-21.80 | ||
| Q3 24 | $0.15 | $-6.00 | ||
| Q2 24 | $0.13 | $-3.00 | ||
| Q1 24 | $0.08 | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $87.6M | $3.0M |
| 总债务越低越好 | $72.1M | $4.5M |
| 股东权益账面价值 | $477.3M | $-9.8M |
| 总资产 | $624.2M | $5.8M |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资ADMAAIM
| Q4 25 | $87.6M | $3.0M | ||
| Q3 25 | $61.4M | $2.4M | ||
| Q2 25 | $90.3M | $835.0K | ||
| Q1 25 | $71.6M | $2.2M | ||
| Q4 24 | $103.1M | $4.0M | ||
| Q3 24 | $86.7M | $7.2M | ||
| Q2 24 | $88.2M | $10.1M | ||
| Q1 24 | $45.3M | $10.9M |
总债务ADMAAIM
| Q4 25 | $72.1M | $4.5M | ||
| Q3 25 | $72.4M | — | ||
| Q2 25 | — | $2.7M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | $72.3M | $2.8M | ||
| Q3 24 | — | $3.3M | ||
| Q2 24 | — | $3.3M | ||
| Q1 24 | — | $3.3M |
股东权益ADMAAIM
| Q4 25 | $477.3M | $-9.8M | ||
| Q3 25 | $431.2M | $-6.1M | ||
| Q2 25 | $398.3M | $-6.5M | ||
| Q1 25 | $373.4M | $-3.9M | ||
| Q4 24 | $349.0M | $-1.3M | ||
| Q3 24 | $231.9M | $2.9M | ||
| Q2 24 | $188.3M | $6.1M | ||
| Q1 24 | $153.7M | $4.8M |
总资产ADMAAIM
| Q4 25 | $624.2M | $5.8M | ||
| Q3 25 | $568.7M | $5.5M | ||
| Q2 25 | $558.4M | $4.1M | ||
| Q1 25 | $510.6M | $6.2M | ||
| Q4 24 | $488.7M | $8.6M | ||
| Q3 24 | $390.6M | $13.6M | ||
| Q2 24 | $376.4M | $15.7M | ||
| Q1 24 | $350.9M | $16.2M |
负债/权益比ADMAAIM
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $-2.0M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | — |
| 自由现金流率自由现金流/营收 | 24.8% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 0.72× | — |
| 过去12个月自由现金流最近4个季度 | $27.8M | — |
8季度趋势，按日历期对齐
经营现金流ADMAAIM
| Q4 25 | $35.6M | $-2.0M | ||
| Q3 25 | $13.3M | $-5.1M | ||
| Q2 25 | $21.1M | $-1.5M | ||
| Q1 25 | $-19.7M | $-2.4M | ||
| Q4 24 | $50.2M | $-4.0M | ||
| Q3 24 | $25.0M | $-3.1M | ||
| Q2 24 | $45.6M | $-3.0M | ||
| Q1 24 | $-2.2M | $-4.8M |
自由现金流ADMAAIM
| Q4 25 | $34.6M | — | ||
| Q3 25 | $-1.1M | — | ||
| Q2 25 | $18.7M | — | ||
| Q1 25 | $-24.4M | — | ||
| Q4 24 | $47.5M | — | ||
| Q3 24 | $24.0M | — | ||
| Q2 24 | $43.6M | — | ||
| Q1 24 | $-4.6M | — |
自由现金流率ADMAAIM
| Q4 25 | 24.8% | — | ||
| Q3 25 | -0.8% | — | ||
| Q2 25 | 15.3% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | 40.4% | — | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 40.7% | — | ||
| Q1 24 | -5.6% | — |
资本支出强度ADMAAIM
| Q4 25 | 0.8% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 2.0% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 2.9% | — |
现金转化率ADMAAIM
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.62× | — | ||
| Q1 25 | -0.73× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | -0.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
